RISULTATI A DISTANZA DELLA CHEMIOTERAPIA M-VAC SEMPLIFICATA NEGLI UROTELIOMI METASTATIZZATI

Translated title of the contribution: Long-term results of simplified M-VAC chemotherapy in metastatic urothelial cancer

G. Pizzocaro, A. Milani, l. Piva, M. Faustini

Research output: Contribution to journalArticle

Abstract

Between 1985 and 1989, 22 patients with metastatic urothelial cancer (18 bladder, 3 upper urinary tract and 1 urethra) were treated with 4 courses of 'simplified' M-VAC combination chemotherapy (omission of therapy on day 22). Therapy could be recycled every 4 weeks in all cases, and on day 15 had to be omitted only in 12% of courses, hematologic toxicity was moderate and non significant renal toxicity occurred. Six patients (28%) presented complete remission and 9 (40%) were partial responders. Four patients (18%) are still alive and are disease-free after 45 to 60 months. Omission of therapy on day 22 in M-VAC combination chemotherapy makes the treatment tolerable, while activity seems to be unchanged, probably because patients can respect the schedule.

Translated title of the contributionLong-term results of simplified M-VAC chemotherapy in metastatic urothelial cancer
Original languageItalian
Pages (from-to)81-82
Number of pages2
JournalActa Urologica Italica
Volume7
Issue numberSUPPL. 2
Publication statusPublished - 1993

ASJC Scopus subject areas

  • Urology

Fingerprint Dive into the research topics of 'Long-term results of simplified M-VAC chemotherapy in metastatic urothelial cancer'. Together they form a unique fingerprint.

  • Cite this